Suchergebnisse - "Tong, Lexian"

PubPharm (25)

1

Design, synthesis, and antitumor activity evaluation of potent fourth-generation EGFR inhibitors for treatment of Osimertinib resistant non-small cell lung cancer (NSCLC)

enthalten in: Bioorganic chemistry | 2024

von Zhang, Y. | Tong, L. | Yan, F. | +3

2

Design, synthesis and biological evaluation of 2-aminopyrimidine derivatives as potent FLT3 inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2023

von Lian, X. | Gao, Y. | Li, X. | +5

3

2-polysubstituted aromatic ring-pyrimidine derivatives, preparation and medical application thereof

enthalten in: Europäisches Patentamt | 2023

von LIU TAO | LI JIA | HU YONGZHOU | +8

4

Discovery of 2-Aminopyrimidine Derivatives as Potent Dual FLT3/CHK1 Inhibitors with Significantly Reduced hERG Inhibitory Activities

enthalten in: Journal of medicinal chemistry | 2023

von Li, X. | Wang, P. | Wang, C. | +8

5

Compound for virus 3CL protease inhibitor, composition and application thereof

enthalten in: Europäisches Patentamt | 2023

von YANG BO | TONG LEXIAN | DONG XIAOWU | +4

6

Compound for virus 3CL protease inhibitor, composition and application thereof

enthalten in: Europäisches Patentamt | 2023

von YANG BO | TONG LEXIAN | DONG XIAOWU | +4

7

Condensed cyclo-2-aminopyrimidine compound as well as composition and application thereof

enthalten in: Europäisches Patentamt | 2023

von TONG LEXIAN | YANG BO | HE QIAOJUN | +3

8

Condensed cyclo-2-aminopyrimidine compound as well as composition and application thereof

enthalten in: Europäisches Patentamt | 2023

von TONG LEXIAN | YANG BO | HE QIAOJUN | +3

9

Dual inhibition of CHK1/FLT3 enhances cytotoxicity and overcomes adaptive and acquired resistance in FLT3-ITD acute myeloid leukemia

enthalten in: Leukemia | 2023

von Jiang, K. | Li, X. | Wang, C. | +14

10

2-polysubstituted aromatic ring-pyrimidine derivatives, preparation and medical application thereof

enthalten in: Europäisches Patentamt | 2023

von LIU TAO | LI JIA | HU YONGZHOU | +8